Quinolone antimicrobial agents: Adverse effects and bacterial resistance
- 1 December 1989
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (12) , 1080-1092
- https://doi.org/10.1007/bf01975175
Abstract
Adverse effects, drug-drug interactions and bacterial resistance to the new quinolone antimicrobial agents are reviewed. Clinical adverse effects are reported to occur in 5–10% of patients, and include primarily gastrointestinal disturbances, central nervous system toxicity and rash. Laboratory abnormalities are reported to occur in 5–12% of patients, and include mild reversible elevations of transaminases. Quinolones are not recommended in persons whose bone growth is incomplete or in pregnant or nursing women because cartilage toxicity has been observed in juvenile beagles. Drug-drug interactions may occur between quinolones and theophylline, caffeine, and magnesium- or aluminium-containing compounds such as antacids and sucralfate. Bacterial resistance occurs by chromosomal mutations which alter the target enzyme DNA gyrase or decrease drug accumulation. Emergence of resistance during therapy is uncommon to date but can be problematic in infections withPseudomonas aeruginosa, Staphylococcus aureus and other bacteria for which the therapeutic index may be low. In summary, quinolones thus far have been well tolerated, but more experience is needed to determine the exact nature and extent of adverse effects and emergence of bacterial resistance.Keywords
This publication has 130 references indexed in Scilit:
- Development of resistance during antibiotic therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- OfloxacinDrugs, 1987
- Ciprofloxacin in the treatment of urinary tract infection due to enterobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Ciprofloxacin in the treatment of acute bacterial diarrhea: A double blind studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Evaluation of ciprofloxacin in the treatment ofPseudomonas aeruginosa infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Clinical experience with ciprofloxacin in the USAEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- In vitro emergence ofEscherichia coli andPseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- DNA gyrase (Topoisomerase II) from PseudomonasaeruginosaBiochemical and Biophysical Research Communications, 1983
- TOXICOLOGICAL STUDIES ON PIPEMIDIC ACID. V. EFFECT ON DIARTHRODIAL JOINTS OF EXPERIMENTAL ANIMALSThe Journal of Toxicological Sciences, 1978